Quick Answer
BRAINSTORM CELL THERAPEUTICS INC. reported Shares Outstanding of 11.03 million shares for fiscal year 2025.
BRAINSTORM CELL THERAPEUTICS INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 11.03M | +79.7% |
| 2024 | 6.14M | +52.3% |
| 2023 | 4.03M | -89.0% |
| 2022 | 36.69M | +0.8% |
| 2021 | 36.40M | +3.5% |
| 2020 | 35.16M | +51.7% |
| 2019 | 23.17M | +11.6% |
| 2018 | 20.76M | +9.4% |
| 2017 | 18.98M | +1.5% |
| 2016 | 18.69M | +0.2% |
| 2015 | 18.64M | +22.0% |
| 2014 | 15.28M | +30.0% |
| 2013 | 11.75M | -92.2% |
| 2012 | 150.09M | +18.7% |
| 2011 | 126.44M | +31.9% |
| 2010 | 95.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 11.03M | +107.8% | +9.0% |
| June 30, 2025 | 10.12M | -87.3% | +27.9% |
| March 31, 2025 | 7.91M | -88.4% | +28.8% |
| December 31, 2024 | 6.14M | +52.3% | +15.7% |
| September 30, 2024 | 5.31M | -88.3% | -93.3% |
| June 30, 2024 | 79.65M | +94.6% | +16.4% |
| March 31, 2024 | 68.45M | +77.9% | +1597.3% |
| December 31, 2023 | 4.03M | -89.0% | -91.1% |
- BRAINSTORM CELL THERAPEUTICS INC. showed an increase of +79.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, BRAINSTORM CELL THERAPEUTICS INC.’s shares outstanding has declined by 88.5% (from 95.83 million shares to 11.03 million shares).
- The most recent figure is from BRAINSTORM CELL THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: